Post-ustekinumab induction IL12, IL23, and ustekinumab levels are associated with clinical response in a multi-centre prospective cohort study of Crohn’s disease patients: results from the AURORA Study including ANZIBDC Cohort

  • Yoon-Kyo An
  • , Niamh Lindsay
  • , Natalie Allan
  • , Emi Khoo
  • , Richard Fernandes
  • , Anna Amiss
  • , H Pham
  • , Soong-Yuan Ooi
  • , Lena Thin
  • , Daniel Lightowler
  • , Susan Connor
  • , Astrid-Jane Williams
  • , Peter De Cruz
  • , Christopher Li Wai Suen
  • , Viraj Kariyawasam
  • , Nicola Mitrev
  • , Simon Ghaly
  • , Jane M. Andrews
  • , Britt Christensen
  • , Miles P. Sparrow
    • Lauren White, Robert Bryant, Nik Ding, Rupert W. Leong, Daniel van Langenberg, Hans Seltenreich, Kavitha Subramaniam, Graham Radford-Smith, Jakob Begun

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Fingerprint

Dive into the research topics of 'Post-ustekinumab induction IL12, IL23, and ustekinumab levels are associated with clinical response in a multi-centre prospective cohort study of Crohn’s disease patients: results from the AURORA Study including ANZIBDC Cohort'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology